Under the leadership of Jia-Chi (Jack) Wang, M.D., Ph.D., FACMG, FCCMG and Joyce Murata-Collins, Ph.D., ABMGG, the Cytogenetics Service performs over 8,000 diagnostic cancer cytogenetic and fluorescence in situ hybridization (FISH) procedures annually with an overall abnormality rate of approximately 32.2 percent. Testing to detect and characterize leukemias, lymphomas and solid tumors is performed on fresh and archival FFPE (formalin-fixed, paraffin-embedded) tissues.

Cytogenetics is certified under the Clinical Laboratory Improvements Amendments of 1988 (CLIA ID No. 05D0665695), licensed by the State of California (CDF 268), and accredited by the College of American Pathologists (CAP No. 2290001).